2018 AMI Online Salon
ATR-inhibitor: A Novel Approach to Targeting the Achilles’ Heel of Cancer

Project Details
- Artist(s): Felix Donghwi Son; Mississauga, Ontario
- Client: Faculty Advisor: Derek Ng
- Copyright: © 2018 Felix Donghwi Son
- Medium / software used: Chimera, Maxon Cinema4D, Adobe Photoshop, and Adobe Illustrator
- Final presentation format: Print, Journal
- Primary audience: Educated Lay Audience
Project Description
DNA-damaging agents are a cornerstone of cancer treatment. However, their effectiveness is limited by the DNA-damage response in cancer cells. ATR, a protein kinase, is a critical regulator of this DNA repair pathway and is a novel therapeutic target for drug design. I created this two-page spread for a popular science magazine to illustrate the mechanism of action for VX-970, an ATR-inhibitor and cancer suppressor. I summarized ATR suppression into five steps showing the mechanism at both microscopic and molecular levels. A combination of colour-coding scheme, depth of field, and simplicity in background design were used to enhance communication clarity.
Explore more of the 2017 AMI Salon:
- All
- :: (PRO)FESSIONAL
- :: (ST)UDENT
- A-1. PRO Non-Com
- A-2. PRO Com
- B. PRO Editorial
- C. PRO Ad
- D. PRO Med-Legal
- E. PRO Book
- F-1 PRO Anim Non-Com
- F-2 PRO Anim Com
- F-3. PRO Anim Ad
- F-4. PRO Anim Med-Legal
- G-1. PRO Intactv Non-Com
- G-2. PRO Intactv Com
- G-3. PRO Interactive Ad
- G-4. PRO Games
- G-5. PRO Interactive Text
- H. PRO Sim/Pros/Sculpt
- I-1. ST Anat/Path
- I-2. ST Surgi/Clinical
- I-3. ST Molec/Bio
- J. ST Editorial
- K. ST Ad
- L. ST Anim
- M. ST Interactive